Recursion Pharmaceuticals Inc (RXRX)
8.59
-0.20
(-2.28%)
USD |
NASDAQ |
May 08, 16:00
8.65
+0.06
(+0.70%)
After-Hours: 20:00
Recursion Pharmaceuticals Price: 8.59 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 08, 2024 | 8.56 | 8.765 | 8.43 | 8.59 | 2.552M |
| May 07, 2024 | 8.90 | 9.05 | 8.57 | 8.79 | 3.215M |
| May 06, 2024 | 8.93 | 9.21 | 8.82 | 8.94 | 3.367M |
| May 03, 2024 | 9.24 | 9.40 | 8.70 | 8.84 | 3.982M |
| May 02, 2024 | 8.47 | 8.79 | 8.30 | 8.79 | 3.873M |
| May 01, 2024 | 7.75 | 8.75 | 7.73 | 8.34 | 5.750M |
| Apr 30, 2024 | 8.06 | 8.262 | 7.80 | 7.82 | 3.850M |
| Apr 29, 2024 | 8.30 | 8.545 | 8.09 | 8.20 | 4.109M |
| Apr 26, 2024 | 7.86 | 8.139 | 7.68 | 8.12 | 4.394M |
| Apr 25, 2024 | 7.57 | 7.885 | 7.48 | 7.84 | 4.382M |
| Apr 24, 2024 | 8.15 | 8.27 | 7.89 | 7.94 | 7.206M |
| Apr 23, 2024 | 7.56 | 7.92 | 7.55 | 7.70 | 5.111M |
| Apr 22, 2024 | 7.46 | 7.79 | 7.205 | 7.60 | 3.946M |
| Apr 19, 2024 | 7.30 | 7.44 | 7.135 | 7.35 | 4.014M |
| Apr 18, 2024 | 7.35 | 7.58 | 7.27 | 7.40 | 2.862M |
| Apr 17, 2024 | 7.64 | 7.71 | 7.43 | 7.47 | 3.508M |
| Apr 16, 2024 | 7.61 | 7.77 | 7.51 | 7.57 | 3.848M |
| Apr 15, 2024 | 8.41 | 8.458 | 7.77 | 7.79 | 5.149M |
| Apr 12, 2024 | 8.80 | 8.925 | 8.315 | 8.41 | 3.428M |
| Apr 11, 2024 | 8.65 | 8.94 | 8.50 | 8.92 | 3.149M |
| Apr 10, 2024 | 8.61 | 8.778 | 8.41 | 8.58 | 3.752M |
| Apr 09, 2024 | 9.00 | 9.22 | 8.95 | 9.09 | 2.596M |
| Apr 08, 2024 | 8.91 | 9.12 | 8.79 | 9.00 | 3.129M |
| Apr 05, 2024 | 8.534 | 8.94 | 8.41 | 8.87 | 3.413M |
| Apr 04, 2024 | 9.02 | 9.33 | 8.71 | 8.73 | 4.724M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.56
Minimum
May 02 2023
41.33
Maximum
Jul 13 2021
12.77
Average
9.60
Median
Aug 04 2022
Price Benchmarks
| Eli Lilly and Co | 775.00 |
| Palatin Technologies Inc | 2.05 |
| Oragenics Inc | 1.21 |
| Actinium Pharmaceuticals Inc | 8.71 |
| Marinus Pharmaceuticals Inc | 1.43 |
Price Related Metrics
| PS Ratio | 40.60 |
| PEG Ratio | -0.3748 |
| Price to Book Value | 4.349 |
| Earnings Yield | -18.28% |
| Market Cap | 2.016B |
| PEGY Ratio | -0.3748 |